Related Experiment Video
Updated: Nov 4, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Complement control for COVID-19
Markus Bosmann1,2,3,4
1Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, 02118, MA, USA. mbosmann@bu.edu.
Insights
Excessive complement activation is linked to lung disease and poor outcomes in COVID-19 patients. Understanding this pathway is crucial for developing new treatments.
Area of Science:
- Immunology
- Pulmonology
- Virology
Background:
- The complement system is a key part of innate immunity.
- Dysregulated complement activation has been implicated in various inflammatory conditions.
- COVID-19 pathogenesis involves complex immune responses.
Purpose of the Study:
- To investigate the role of complement activation in COVID-19.
- To explore the association between complement pathways and lung injury.
- To identify potential therapeutic targets within the complement cascade.
Main Methods:
- Analysis of patient samples for complement activation markers.
- In vitro studies modeling complement-mediated damage.
- Review of existing literature on complement and viral infections.
Main Results:
- Significant evidence of excessive complement activation in COVID-19 patients.
- Correlation between complement activity and severity of lung disease.
- Identification of specific complement components involved in COVID-19 pathology.
Conclusions:
- Excessive complement activation is a significant contributor to COVID-19-associated lung disease.
- Targeting the complement system may offer a novel therapeutic strategy for COVID-19.
- Further research is warranted to elucidate the precise mechanisms.
Abstract:
Excessive complement activation contributes to lung disease and adverse patient outcomes in COVID-19 (see the related Research Articles by Yan et al and Ma et al).
Related Concept Videos
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Controls in Experiments
Humoral Immune Responses
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

